Elucidation of the Molecular Mechanisms Underlying Sorafenib-Induced Hepatotoxicity

Sorafenib is a small, orally-active multikinase inhibitor that is most frequently used for the management of renal cell carcinoma, hepatocellular carcinoma, and radioactive iodine-resistant thyroid carcinoma. However, recent reports have associated sorafenib with hepatotoxicity that can limit its cl...

Descripción completa

Detalles Bibliográficos
Autores principales: AlAsmari, Abdullah F., Ali, Nemat, AlAsmari, Fawaz, AlAnazi, Wael A., Alqahtani, Faleh, Alharbi, Metab, Alotaibi, Farraj M., Aldossari, Abdullah A., AlSwayyed, Mohammed, Alanazi, Mohammed M., Alshamrani, Ali A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245685/
https://www.ncbi.nlm.nih.gov/pubmed/32509153
http://dx.doi.org/10.1155/2020/7453406

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245685/
https://www.ncbi.nlm.nih.gov/pubmed/32509153
http://dx.doi.org/10.1155/2020/7453406

Ejemplares similares